2022 Prague Declaration
The Time is Now: Achieving FH Paediatric Screening Across Europe
The Prague Declaration is a call to action (7 specific asks) for national and European Union policymakers and decision-makers. It is a political document, which is the result of the Czech EU Presidency meeting on FH Paediatric Screening (early detection of inherited high cholesterol) at the Czech Senate in Prague on 6th September 2022. The Prague event addressed the outstanding barriers to the systematic implementation of FH paediatric screening across Europe and the concrete actions needed to move forward. It also builds on the Technical Meeting of the Slovenian EU Presidency in October 2021.
Endorse the Prague Declaration
We invite national and regional policymakers across the EU, medical societies, patient and public health organisations, and individual experts to support this declaration and to help ensure that FH Paediatric Screening becomes a reality in Europe, as part of European and national strategies to prevent cardiovascular diseases, and to promote cardiovascular health.
If you would like to add your name as a signatory of the Prague Declaration to the EU, national and international institutions on public health, please fill in this form.
Currently Endorsed by:
The following organisations and individuals have endorsed this declaration
Browse the logos of those that have already signed the Prague Declaration to the EU
Individuals in the community that have signed so far:
FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt